Coexpression of CD5 and CD10 is highly unusual in B-cell lymphomas and may pose a
diagnostic challenge. We report 42 cases of B-cell lymphoma with simultaneous expression …

T-cell antigen expression can be observed in B-cell non-Hodgkin lymphoma (B-NHL).
Although CD5 is expressed in B-cell chronic lymphocytic leukemia (B-CLL) and mantle cell …

CD5 is useful for the classification of low-grade B-cell lymphomas, because it is aberrantly
expressed in B-cell chronic lymphocytic leukemias/small lymphocytic lymphomas (B …

We analyzed 53 cases of diffuse large B-cell lymphoma (DLBCL) to determine whether
expression of CD10 is a relevant biologic parameter. Tumor morphologic features were …

The clinical significance and prognostic value of CD10 in de novo diffuse large B-cell
lymphoma (DLBCL) is largely unknown. We retrospectively studied 19 men and 9 women …

CD10 and Bcl10 expression in diffuse large B‐cell lymphoma: CD10 is a marker of improved
prognosis Aims: Diffuse large B‐cell lymphoma (DLBCL), the most common subtype of non …

Mantle cell lymphomas (MCLs) are typically CD5-expressing B-cell non-Hodgkin's
lymphomas (NHLs) that frequently harbor the chromosomal translocation t (11; 14) or bcl-1 …

It is not uncommon for some B-lineage non-Hodgkin lymphomas (NHLs) to aberrantly
coexpress T-cell markers, particularly CD5, as well as CD7, CD2, CD4, and/or CD8 in rare …

Abstract We studied 61 CD20–B-cell lymphomas, including 29 cases of precursor B-cell
lymphoblastic leukemia/lymphoblastic lymphoma (B-ALL/B-LBL), 25 cases of CD20 …

Diffuse large B-cell lymphoma (DLBCL) is a common morphologic term for a biologically
diverse group of lymphomas. The chromosome translocation, t (14; 18)(q32; q21), and its …